Cardiovascular Disease Prevention
Conditions
Keywords
Daily walking, Step count, Smartphone application, Physical activity, Body composition, Psychological well-being, Stress, Anxiety
Brief summary
This study evaluated whether a three-month smartphone-supported daily walking intervention could improve physical activity, psychological well-being, and body composition in adults with cardiometabolic disease. Participants had cardiovascular disease and/or type 2 diabetes and used the Walk15 smartphone platform to monitor daily step count. The intervention aimed to increase daily walking by approximately 1,000 steps per day through individualized step goals, self-monitoring, and digital feedback. Outcomes were assessed before and after the intervention and included daily step count, body composition, handgrip strength, sleep duration, eating behaviors, subjective well-being, vigor, stress, anxiety, health, and happiness.
Detailed description
This was a three-month quasi-experimental longitudinal study in adults aged 20 to 65 years with physician-confirmed cardiovascular disease and/or type 2 diabetes mellitus. The intervention was delivered through the Walk15 smartphone platform. Participants received individualized step goals based on baseline activity levels and were encouraged to increase daily walking gradually, aiming for approximately 1,000 additional steps per day. Daily step counts were monitored through smartphone-connected wearable devices and synchronized with the Walk15 platform. No dietary modifications, weight-loss program, or structured exercise training were prescribed. The study assessed changes in physical activity, psychological well-being, lifestyle behaviors, muscle strength, and body composition from baseline to the end of the three-month intervention.
Interventions
BEHAVIORALSmartphone-Supported Daily Walking
Participants received a three-month smartphone-supported walking intervention delivered through the Walk15 platform. Individualized step goals were established based on baseline daily step counts. Participants were encouraged to increase daily walking by approximately 1,000 steps per day, progressing gradually during the first month. Daily step counts were monitored using smartphone-connected wearable devices and synchronized with the Walk15 platform. Participants received feedback through the platform to support adherence. No dietary modifications, weight-loss program, or structured exercise training were prescribed.
Sponsors
Klaipėda University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
All participants were assigned to a single smartphone-supported walking intervention group. There was no randomized control group. Outcomes were assessed before and after the three-month intervention.
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Adults aged 20 to 65 years Physician-confirmed diagnosis of cardiovascular disease and/or type 2 diabetes mellitus verified through medical records Medical clearance from the treating physician confirming that participation in a walking-based physical activity program was safe and appropriate Ability to use the Walk15 smartphone platform or smartphone-connected wearable device for step-count monitoring Written informed consent provided before enrollment
Exclusion criteria
* Severe mobility limitations Acute medical conditions Psychiatric disorders requiring pharmacological treatment Inability to complete baseline or post-intervention assessments
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Daily Step Count | Baseline to 3 months | Daily step count was assessed using the Walk15 smartphone platform, which synchronized step-count data from participants' smartphones and wearable devices. Change was calculated as the difference between baseline daily step count and post-intervention daily step count. |
Countries
Lithuania
Contacts
STUDY_CHAIRAlbertas Skurvydas, dr
KU
Outcome results
None listed